Sopheon plc is a software-application business based in the UK. Sopheon shares (SPE.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Sopheon employs 163 staff and has a trailing 12-month revenue of around £30.4 million.
|Latest market close||N/Ap|
|52-week range||477.8775p - 975p|
|50-day moving average||801.3236p|
|200-day moving average||825.3873p|
|Wall St. target price||16.36p|
|Dividend yield||0.03p (0.38%)|
|Earnings per share (TTM)||16.4p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Sopheon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sopheon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sopheon's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 53x. In other words, Sopheon shares trade at around 53x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Sopheon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £2.4 million.
The EBITDA is a measure of a Sopheon's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||£30.4 million|
|Operating margin TTM||6.84%|
|Gross profit TTM||£21.2 million|
|Return on assets TTM||3.27%|
|Return on equity TTM||6.41%|
|Market capitalisation||£88.3 million|
TTM: trailing 12 months
Dividend payout ratio: 24.51% of net profits
Recently Sopheon has paid out, on average, around 24.51% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.38% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Sopheon shareholders could enjoy a 0.38% return on their shares, in the form of dividend payments. In Sopheon's case, that would currently equate to about 0.03p per share.
While Sopheon's payout ratio might seem low, this can signify that Sopheon is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 11 June 2020 (the "ex-dividend date").
Sopheon's shares were split on a 500:1 basis on 22 December 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 500 shares. This wouldn't directly have changed the overall worth of your Sopheon shares – just the quantity. However, indirectly, the new 99.8% lower share price could have impacted the market appetite for Sopheon shares which in turn could have impacted Sopheon's share price.
Over the last 12 months, Sopheon's shares have ranged in value from as little as 477.8775p up to 975p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Sopheon's is 0.9387. This would suggest that Sopheon's shares are less volatile than average (for this exchange).
Sopheon plc designs, develops, and markets software products with associated implementation and consultancy services in North America and Europe. The company's software products comprise Accolade, Accolade Express, Accolade Cloud, Accolade Go, Accolade Integration, and Accolade Accelerators. Its solutions provide support for innovation planning, road mapping, idea and concept development, process and project management, portfolio management and optimization, and resource planning, as well as analytics, collaborative workflow, product lifecycle management, stage-gate automation, capital expenditure management, and strategic initiative management and innovation planning. The company also offers services, such as assessments, consulting, implementation, training, and support; and maintenance, hosting, and cloud services, as well as software as a service. It serves customers in the aerospace and defense, automotive, chemical and coatings, consumer goods, food and beverage, high tech, industrial, and other sectors. The company was formerly known as PolyDoc and changed its name to Sopheon plc in 1999. Sopheon plc was founded in 1993 and is based in West End, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.